IDH2 and central nervous system cancer: Furthermore, it has enabled us to define CNV heterogeneity within different tumor niches in IDH-mutant and IDH-wild-type high-grade gliomas, including between necrotic tumor core and infiltrative tumor margin (Fig. 2a).